Cytek Biosciences, Inc. (CTKB)
5.59
+0.16
(+2.95%)
USD |
NASDAQ |
Oct 23, 16:00
5.59
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Price to Book Value : 2.257 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.257 |
| October 22, 2026 | 2.192 |
| October 21, 2026 | 2.220 |
| October 20, 2026 | 2.156 |
| October 19, 2026 | 2.120 |
| October 16, 2026 | 2.120 |
| October 15, 2026 | 2.184 |
| October 14, 2026 | 2.178 |
| October 13, 2026 | 2.16 |
| October 12, 2026 | 2.144 |
| October 09, 2026 | 2.192 |
| October 08, 2026 | 2.164 |
| October 07, 2026 | 2.156 |
| October 06, 2026 | 2.172 |
| October 05, 2026 | 2.459 |
| October 02, 2026 | 2.370 |
| October 01, 2026 | 2.346 |
| September 30, 2026 | 2.406 |
| September 29, 2026 | 2.326 |
| September 28, 2026 | 2.317 |
| September 25, 2026 | 2.281 |
| September 24, 2026 | 2.313 |
| September 23, 2026 | 2.293 |
| September 22, 2026 | 2.305 |
| September 21, 2026 | 2.132 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.140 |
| September 17, 2026 | 2.103 |
| September 16, 2026 | 1.990 |
| September 15, 2026 | 1.974 |
| September 14, 2026 | 1.95 |
| September 11, 2026 | 1.861 |
| September 10, 2026 | 1.829 |
| September 09, 2026 | 1.910 |
| September 08, 2026 | 1.865 |
| September 04, 2026 | 1.898 |
| September 03, 2026 | 1.898 |
| September 02, 2026 | 1.894 |
| September 01, 2026 | 1.865 |
| August 31, 2026 | 1.930 |
| August 28, 2026 | 1.890 |
| August 27, 2026 | 1.865 |
| August 26, 2026 | 1.845 |
| August 25, 2026 | 1.849 |
| August 24, 2026 | 1.793 |
| August 21, 2026 | 1.942 |
| August 20, 2026 | 1.881 |
| August 19, 2026 | 1.898 |
| August 18, 2026 | 1.885 |
| August 17, 2026 | 1.914 |
| August 14, 2026 | 1.894 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agilent Technologies, Inc. | 6.628 |
| Bio-Rad Laboratories, Inc. | 1.379 |
| Bruker Corp. | 3.684 |
| Danaher Corp. | 3.024 |
| Harvard Bioscience, Inc. | 5.051 |
Price to Book Value Related Metrics
| PS Ratio | 3.474 |
| PEG Ratio | -0.0079 |
| Price | 5.59 |
| Earnings Yield | -11.22% |
| Market Cap | 726.60M |
| PEGY Ratio | -0.0079 |